So Y, Chan C, Fung S, Lui T, Lau F, Chan K
Soc Psychiatry Psychiatr Epidemiol. 2023; 59(7):1215-1225.
PMID: 37833425
DOI: 10.1007/s00127-023-02563-4.
Donmezler S, Iskender G, Fistikci N, Altunkaynak Y, Ulusoy S, Berkol T
Alpha Psychiatry. 2023; 24(3):102-107.
PMID: 37440902
PMC: 10334689.
DOI: 10.5152/alphapsychiatry.2023.221030.
Choi Y, Kweon Y
Patient Prefer Adherence. 2023; 17:1247-1255.
PMID: 37201154
PMC: 10187643.
DOI: 10.2147/PPA.S408781.
Siebert S, Leopold K, Baumgardt J, von Hardenberg L, Burkhardt E, Bechdolf A
Eur Arch Psychiatry Clin Neurosci. 2022; 272(7):1-14.
PMID: 35141809
PMC: 9508217.
DOI: 10.1007/s00406-022-01379-8.
El Abdellati K, De Picker L, Morrens M
Front Neurosci. 2020; 14:531763.
PMID: 33162877
PMC: 7584050.
DOI: 10.3389/fnins.2020.531763.
The Association Between Medication Adherence and Disease Stability in Patients with Severe Mental Disorders and Area Variation: Community-Based Prospective Study in Southwest China.
Li Y, Wen H, Xu J, Wang D, Liu Y, Yang M
Community Ment Health J. 2019; 56(2):322-327.
PMID: 31529173
DOI: 10.1007/s10597-019-00460-2.
Medication adherence in first episode psychosis: the role of pre-onset subthreshold symptoms.
Daneault J, Maraj A, Lepage M, Malla A, Schmitz N, Iyer S
Acta Psychiatr Scand. 2019; 139(4):336-347.
PMID: 30712261
PMC: 6426680.
DOI: 10.1111/acps.13011.
The RAISE Connection Program: Psychopharmacological Treatment of People With a First Episode of Schizophrenia.
Kreyenbuhl J, Medoff D, McEvoy J, Smith T, Hackman A, Nossel I
Psychiatr Serv. 2016; 67(12):1300-1306.
PMID: 27364816
PMC: 5633208.
DOI: 10.1176/appi.ps.201500438.
Adherence to Antipsychotic Medication in Bipolar Disorder and Schizophrenic Patients: A Systematic Review.
Garcia S, Martinez-Cengotitabengoa M, Lopez-Zurbano S, Zorrilla I, Lopez P, Vieta E
J Clin Psychopharmacol. 2016; 36(4):355-71.
PMID: 27307187
PMC: 4932152.
DOI: 10.1097/JCP.0000000000000523.
The Promises and Challenges of Ecological Momentary Assessment in Schizophrenia: Development of an Initial Experimental Protocol.
Gaudiano B, Moitra E, Ellenberg S, Armey M
Healthcare (Basel). 2015; 3(3):556-73.
PMID: 26689969
PMC: 4683929.
DOI: 10.3390/healthcare3030556.
Outpatient Follow-Up Visit after Hospital Discharge Lowers Risk of Rehospitalization in Patients with Schizophrenia: A Nationwide Population-Based Study.
Lee S, Kim K, Kim T, Kim S, Kim J, Han C
Psychiatry Investig. 2015; 12(4):425-33.
PMID: 26508952
PMC: 4620298.
DOI: 10.4306/pi.2015.12.4.425.
How to study determinants related to medication adherence in newly diagnosed polyarthritis patients for the development of a prediction instrument.
Pasma A, Hazes J, Luime J, Busschbach J, van t Spijker A
Patient Prefer Adherence. 2014; 8:1437-47.
PMID: 25349475
PMC: 4208351.
DOI: 10.2147/PPA.S66922.
Predictors of medication non-adherence in Bulgarian outpatients with schizophrenia.
Vassileva I, Milanova V, Asan T
Community Ment Health J. 2014; 50(7):854-61.
PMID: 24452824
DOI: 10.1007/s10597-014-9697-8.
Suboptimal treatment adherence in bipolar disorder: impact on clinical outcomes and functioning.
Montes J, Maurino J, Dios C, Medina E
Patient Prefer Adherence. 2013; 7:89-94.
PMID: 23378745
PMC: 3553333.
DOI: 10.2147/PPA.S39290.
Are attitudes towards medication adherence associated with medication adherence behaviours among patients with psychosis? A systematic review and meta analysis.
Richardson M, McCabe R, Priebe S
Soc Psychiatry Psychiatr Epidemiol. 2012; 48(4):649-57.
PMID: 22961288
DOI: 10.1007/s00127-012-0570-1.
The predictive validity of subjective adherence measures in patients with schizophrenia.
Kikkert M, Koeter M, Dekker J, Burti L, Robson D, Puschner B
Int J Methods Psychiatr Res. 2011; 20(2):73-81.
PMID: 21557378
PMC: 6878246.
DOI: 10.1002/mpr.335.
Description of study population and analysis of factors influencing adherence in the observational Italian study "Evaluation of Pharmacotherapy Adherence in Bipolar Disorder" (EPHAR).
Barraco A, Rossi A, Nicolo G
CNS Neurosci Ther. 2011; 18(2):110-8.
PMID: 21199448
PMC: 6493623.
DOI: 10.1111/j.1755-5949.2010.00225.x.
Partial adherence to antipsychotic medication impacts the course of illness in patients with schizophrenia: a review.
Masand P, Roca M, Turner M, Kane J
Prim Care Companion J Clin Psychiatry. 2009; 11(4):147-54.
PMID: 19750066
PMC: 2736032.
DOI: 10.4088/PCC.08r00612.
A prospective study of cannabis use as a risk factor for non-adherence and treatment dropout in first-episode schizophrenia.
Miller R, Ream G, McCormack J, Gunduz-Bruce H, Sevy S, Robinson D
Schizophr Res. 2009; 113(2-3):138-44.
PMID: 19481424
PMC: 2726744.
DOI: 10.1016/j.schres.2009.04.018.
An approach to maximizing treatment adherence of children and adolescents with psychotic disorders and major mood disorders.
Gearing R, Mian I
Can Child Adolesc Psychiatr Rev. 2008; 14(4):106-13.
PMID: 19030524
PMC: 2553227.